Arbutus Biopharma Corp
NASDAQ:ABUS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arbutus Biopharma Corp
NASDAQ:ABUS
|
US |
|
R
|
Resonac Holdings Corp
XMUN:SWD
|
JP |
|
M
|
Mark Dynamics Indonesia Tbk PT
IDX:MARK
|
ID |
Intrinsic Value
The
intrinsic value for
Arbutus Biopharma Corp (ABUS)
under the Base Case is
0.52
USD.
Compared with the current market price of 4.52 USD, the stock appears
Overvalued by 89%.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Arbutus Biopharma Corp.
Fundamental Analysis
Revenue & Expenses Breakdown
Arbutus Biopharma Corp
Earnings Waterfall
Arbutus Biopharma Corp
The
intrinsic value for
Arbutus Biopharma Corp (ABUS)
under the Base Case is
0.52
USD.
Compared with the current market price of 4.52 USD, the stock appears Overvalued by 89%.